Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by offering

1.4.2. Market size breakdown, by allergen

1.4.3. Market size breakdown, by test type

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Volume

1.5.2. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Volume, by Offering (2017–2030)

6.2.1. Instruments market volume, by type (2017–2030)

6.3. Market Revenue, by Offering (2017–2030)

6.3.1. Instruments market revenue, by type (2017–2030)

6.4. Market Volume, by Allergen (2017–2030)

6.5. Market Revenue, by Allergen (2017–2030)

6.6. Market Volume, by Test Type (2017–2030)

6.7. Market Revenue, by Test Type (2017–2030)

6.8. Market Volume, by End User (2017–2030)

6.9. Market Revenue, by End User (2017–2030)

6.10. Market Volume, by Region (2017–2030)

6.11. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Volume, by Offering (2017–2030)

7.2.1. Instruments market volume, by type (2017–2030)

7.3. Market Revenue, by Offering (2017–2030)

7.3.1. Instruments market revenue, by type (2017–2030)

7.4. Market Volume, by Allergen (2017–2030)

7.5. Market Revenue, by Allergen (2017–2030)

7.6. Market Volume, by Test Type (2017–2030)

7.7. Market Revenue, by Test Type (2017–2030)

7.8. Market Volume, by End User (2017–2030)

7.9. Market Revenue, by End User (2017–2030)

7.10. Market Volume, by Country (2017–2030)

7.11. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Volume, by Offering (2017–2030)

8.2.1. Instruments market volume, by type (2017–2030)

8.3. Market Revenue, by Offering (2017–2030)

8.3.1. Instruments market revenue, by type (2017–2030)

8.4. Market Volume, by Allergen (2017–2030)

8.5. Market Revenue, by Allergen (2017–2030)

8.6. Market Volume, by Test Type (2017–2030)

8.7. Market Revenue, by Test Type (2017–2030)

8.8. Market Volume, by End User (2017–2030)

8.9. Market Revenue, by End User (2017–2030)

8.10. Market Volume, by Country (2017–2030)

8.11. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Volume, by Offering (2017–2030)

9.2.1. Instruments market volume, by type (2017–2030)

9.3. Market Revenue, by Offering (2017–2030)

9.3.1. Instruments market revenue, by type (2017–2030)

9.4. Market Volume, by Allergen (2017–2030)

9.5. Market Revenue, by Allergen (2017–2030)

9.6. Market Volume, by Test Type (2017–2030)

9.7. Market Revenue, by Test Type (2017–2030)

9.8. Market Volume, by End User (2017–2030)

9.9. Market Revenue, by End User (2017–2030)

9.10. Market Volume, by Country (2017–2030)

9.11. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Volume, by Offering (2017–2030)

10.2.1. Instruments market volume, by type (2017–2030)

10.3. Market Revenue, by Offering (2017–2030)

10.3.1. Instruments market revenue, by type (2017–2030)

10.4. Market Volume, by Allergen (2017–2030)

10.5. Market Revenue, by Allergen (2017–2030)

10.6. Market Volume, by Test Type (2017–2030)

10.7. Market Revenue, by Test Type (2017–2030)

10.8. Market Volume, by End User (2017–2030)

10.9. Market Revenue, by End User (2017–2030)

10.10. Market Volume, by Country (2017–2030)

10.11. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Volume, by Offering (2017–2030)

11.2.1. Instruments market volume, by type (2017–2030)

11.3. Market Revenue, by Offering (2017–2030)

11.3.1. Instruments market revenue, by type (2017–2030)

11.4. Market Volume, by Allergen (2017–2030)

11.5. Market Revenue, by Allergen (2017–2030)

11.6. Market Volume, by Test Type (2017–2030)

11.7. Market Revenue, by Test Type (2017–2030)

11.8. Market Volume, by End User (2017–2030)

11.9. Market Revenue, by End User (2017–2030)

11.10. Market Volume, by Country (2017–2030)

11.11. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Volume, by Offering (2017–2030)

12.2.1. Instruments market volume, by type (2017–2030)

12.3. Market Revenue, by Offering (2017–2030)

12.3.1. Instruments market revenue, by type (2017–2030)

12.4. Market Volume, by Allergen (2017–2030)

12.5. Market Revenue, by Allergen (2017–2030)

12.6. Market Volume, by Test Type (2017–2030)

12.7. Market Revenue, by Test Type (2017–2030)

12.8. Market Volume, by End User (2017–2030)

12.9. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Volume, by Offering (2017–2030)

13.2.1. Instruments market volume, by type (2017–2030)

13.3. Market Revenue, by Offering (2017–2030)

13.3.1. Instruments market revenue, by type (2017–2030)

13.4. Market Volume, by Allergen (2017–2030)

13.5. Market Revenue, by Allergen (2017–2030)

13.6. Market Volume, by Test Type (2017–2030)

13.7. Market Revenue, by Test Type (2017–2030)

13.8. Market Volume, by End User (2017–2030)

13.9. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Volume, by Offering (2017–2030)

14.2.1. Instruments market volume, by type (2017–2030)

14.3. Market Revenue, by Offering (2017–2030)

14.3.1. Instruments market revenue, by type (2017–2030)

14.4. Market Volume, by Allergen (2017–2030)

14.5. Market Revenue, by Allergen (2017–2030)

14.6. Market Volume, by Test Type (2017–2030)

14.7. Market Revenue, by Test Type (2017–2030)

14.8. Market Volume, by End User (2017–2030)

14.9. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Volume, by Offering (2017–2030)

15.2.1. Instruments market volume, by type (2017–2030)

15.3. Market Revenue, by Offering (2017–2030)

15.3.1. Instruments market revenue, by type (2017–2030)

15.4. Market Volume, by Allergen (2017–2030)

15.5. Market Revenue, by Allergen (2017–2030)

15.6. Market Volume, by Test Type (2017–2030)

15.7. Market Revenue, by Test Type (2017–2030)

15.8. Market Volume, by End User (2017–2030)

15.9. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Volume, by Offering (2017–2030)

16.2.1. Instruments market volume, by type (2017–2030)

16.3. Market Revenue, by Offering (2017–2030)

16.3.1. Instruments market revenue, by type (2017–2030)

16.4. Market Volume, by Allergen (2017–2030)

16.5. Market Revenue, by Allergen (2017–2030)

16.6. Market Volume, by Test Type (2017–2030)

16.7. Market Revenue, by Test Type (2017–2030)

16.8. Market Volume, by End User (2017–2030)

16.9. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Volume, by Offering (2017–2030)

17.2.1. Instruments market volume, by type (2017–2030)

17.3. Market Revenue, by Offering (2017–2030)

17.3.1. Instruments market revenue, by type (2017–2030)

17.4. Market Volume, by Allergen (2017–2030)

17.5. Market Revenue, by Allergen (2017–2030)

17.6. Market Volume, by Test Type (2017–2030)

17.7. Market Revenue, by Test Type (2017–2030)

17.8. Market Volume, by End User (2017–2030)

17.9. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Volume, by Offering (2017–2030)

18.2.1. Instruments market volume, by type (2017–2030)

18.3. Market Revenue, by Offering (2017–2030)

18.3.1. Instruments market revenue, by type (2017–2030)

18.4. Market Volume, by Allergen (2017–2030)

18.5. Market Revenue, by Allergen (2017–2030)

18.6. Market Volume, by Test Type (2017–2030)

18.7. Market Revenue, by Test Type (2017–2030)

18.8. Market Volume, by End User (2017–2030)

18.9. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Volume, by Offering (2017–2030)

19.2.1. Instruments market volume, by type (2017–2030)

19.3. Market Revenue, by Offering (2017–2030)

19.3.1. Instruments market revenue, by type (2017–2030)

19.4. Market Volume, by Allergen (2017–2030)

19.5. Market Revenue, by Allergen (2017–2030)

19.6. Market Volume, by Test Type (2017–2030)

19.7. Market Revenue, by Test Type (2017–2030)

19.8. Market Volume, by End User (2017–2030)

19.9. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Volume, by Offering (2017–2030)

20.2.1. Instruments market volume, by type (2017–2030)

20.3. Market Revenue, by Offering (2017–2030)

20.3.1. Instruments market revenue, by type (2017–2030)

20.4. Market Volume, by Allergen (2017–2030)

20.5. Market Revenue, by Allergen (2017–2030)

20.6. Market Volume, by Test Type (2017–2030)

20.7. Market Revenue, by Test Type (2017–2030)

20.8. Market Volume, by End User (2017–2030)

20.9. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Volume, by Offering (2017–2030)

21.2.1. Instruments market volume, by type (2017–2030)

21.3. Market Revenue, by Offering (2017–2030)

21.3.1. Instruments market revenue, by type (2017–2030)

21.4. Market Volume, by Allergen (2017–2030)

21.5. Market Revenue, by Allergen (2017–2030)

21.6. Market Volume, by Test Type (2017–2030)

21.7. Market Revenue, by Test Type (2017–2030)

21.8. Market Volume, by End User (2017–2030)

21.9. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Volume, by Offering (2017–2030)

22.2.1. Instruments market volume, by type (2017–2030)

22.3. Market Revenue, by Offering (2017–2030)

22.3.1. Instruments market revenue, by type (2017–2030)

22.4. Market Volume, by Allergen (2017–2030)

22.5. Market Revenue, by Allergen (2017–2030)

22.6. Market Volume, by Test Type (2017–2030)

22.7. Market Revenue, by Test Type (2017–2030)

22.8. Market Volume, by End User (2017–2030)

22.9. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Volume, by Offering (2017–2030)

23.2.1. Instruments market volume, by type (2017–2030)

23.3. Market Revenue, by Offering (2017–2030)

23.3.1. Instruments market revenue, by type (2017–2030)

23.4. Market Volume, by Allergen (2017–2030)

23.5. Market Revenue, by Allergen (2017–2030)

23.6. Market Volume, by Test Type (2017–2030)

23.7. Market Revenue, by Test Type (2017–2030)

23.8. Market Volume, by End User (2017–2030)

23.9. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Volume, by Offering (2017–2030)

24.2.1. Instruments market volume, by type (2017–2030)

24.3. Market Revenue, by Offering (2017–2030)

24.3.1. Instruments market revenue, by type (2017–2030)

24.4. Market Volume, by Allergen (2017–2030)

24.5. Market Revenue, by Allergen (2017–2030)

24.6. Market Volume, by Test Type (2017–2030)

24.7. Market Revenue, by Test Type (2017–2030)

24.8. Market Volume, by End User (2017–2030)

24.9. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Volume, by Offering (2017–2030)

25.2.1. Instruments market volume, by type (2017–2030)

25.3. Market Revenue, by Offering (2017–2030)

25.3.1. Instruments market revenue, by type (2017–2030)

25.4. Market Volume, by Allergen (2017–2030)

25.5. Market Revenue, by Allergen (2017–2030)

25.6. Market Volume, by Test Type (2017–2030)

25.7. Market Revenue, by Test Type (2017–2030)

25.8. Market Volume, by End User (2017–2030)

25.9. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Volume, by Offering (2017–2030)

26.2.1. Instruments market volume, by type (2017–2030)

26.3. Market Revenue, by Offering (2017–2030)

26.3.1. Instruments market revenue, by type (2017–2030)

26.4. Market Volume, by Allergen (2017–2030)

26.5. Market Revenue, by Allergen (2017–2030)

26.6. Market Volume, by Test Type (2017–2030)

26.7. Market Revenue, by Test Type (2017–2030)

26.8. Market Volume, by End User (2017–2030)

26.9. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Volume, by Offering (2017–2030)

27.2.1. Instruments market volume, by type (2017–2030)

27.3. Market Revenue, by Offering (2017–2030)

27.3.1. Instruments market revenue, by type (2017–2030)

27.4. Market Volume, by Allergen (2017–2030)

27.5. Market Revenue, by Allergen (2017–2030)

27.6. Market Volume, by Test Type (2017–2030)

27.7. Market Revenue, by Test Type (2017–2030)

27.8. Market Volume, by End User (2017–2030)

27.9. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Volume, by Offering (2017–2030)

28.2.1. Instruments market volume, by type (2017–2030)

28.3. Market Revenue, by Offering (2017–2030)

28.3.1. Instruments market revenue, by type (2017–2030)

28.4. Market Volume, by Allergen (2017–2030)

28.5. Market Revenue, by Allergen (2017–2030)

28.6. Market Volume, by Test Type (2017–2030)

28.7. Market Revenue, by Test Type (2017–2030)

28.8. Market Volume, by End User (2017–2030)

28.9. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. bioMerieux S.A.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. Danaher Corporation

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Romer Labs Division Holding GmbH

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. HOB Biotech Group Corp Ltd.

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. HYCOR Biomedical LLC

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. NEOGEN Corporation

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Eurofins Scientific

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. Siemens Healthcare GmbH

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. Stallergenes Greer International AG

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

30.10. Thermo Fisher Scientific

30.10.1. Business overview

30.10.2. Product and service offerings

30.10.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports

※参考情報 アレルギー診断は、アレルギーの原因となる物質や反応を特定し、アレルギーの存在を確認するための方法です。アレルギーは、免疫系が特定の物質に対して過剰に反応することで起こる病態であり、おもに食品、花粉、ダニ、ペットの毛、薬剤などがアレルゲンとなります。 アレルギー診断にはさまざまな種類があり、一般的には皮膚試験、血液検査、パッチテスト、特異的IgE検査などがあります。皮膚試験は、アレルゲンを皮膚に直接投与し、局所反応の有無を観察する方法です。この方法では、いくつかのアレルゲンを同時に試すことができ、反応が出た場合、そのアレルゲンが原因である可能性が高いとされます。 血液検査は、血液中の特異的IgE抗体の量を測定する方法で、特定のアレルゲンに対する感受性を評価するのに役立ちます。特異的IgE検査は簡便であり、腫れている部位に影響を与えずに検査が行えるため、皮膚試験が困難な場合に用いられることがあります。 パッチテストは、皮膚に接触性アレルギーを疑う場合に行われるもので、アレルゲンを含むパッチを皮膚に貼り、数日後に反応をチェックします。これは主に金属や化粧品などに対するアレルギーの診断に用いられます。検査結果は、アレルギーがどの物質によって引き起こされているのかを正確に特定するのに役立ちます。 アレルギー診断の用途は広範囲にわたり、アレルギー性鼻炎、喘息、蕁麻疹、アトピー性皮膚炎、食物アレルギーなど、さまざまな病状の診断と管理に寄与します。これにより、適切な治療法や回避すべきアレルゲンを特定し、患者の生活の質を向上させる手助けとなります。 最近では、新しい技術も続々と登場しています。マルチアレルゲンテストや人工知能を活用した解析技術があり、これらは複数のアレルゲンに対する反応を同時に評価することができ、診断の精度や迅速性を向上させることが期待されています。また、これによりコストの削減や患者負担の軽減にもつながると考えられています。 さらに、遺伝子解析技術もアレルギー診断における新たなアプローチとして注目されています。遺伝的要因がアレルギーの発症に寄与していることが示されているため、遺伝子の変異を解析することで、アレルギー傾向を予測することが可能になるかもしれません。 アレルギー診断における安定性と信頼性を高めるためには、医療機関と患者とのコミュニケーションが重要です。患者が自身の症状や生活環境を正確に医師に伝えることで、適切な診断が促進されます。また、診断データを基にした個別化医療が進展すれば、患者一人ひとりに最適な治療方法が提供できるようになるでしょう。 今後、アレルギー診断技術はさらなる進化を遂げ、多様化するニーズに応えることが求められます。新たなアプローチや研究成果が臨床現場に早期に導入されることで、アレルギーに悩む人々がより良い生活を送るための支援が一層強化されることが期待されます。アレルギーは生活の質に大きな影響を与えるため、一人でも多くの人が適切な診断と治療を受けられるようになることが重要です。